Eric S. Lightcap
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Cell death mechanisms and regulation
Papers in
-
- Ubiquitin and proteasome pathways 13
- Protein Degradation and Inhibitors 3
- Oncology 11
- Cancer-related Molecular Pathways 5
- Cancer Cells and Metastasis 3
- Co-authors
- Vincent Chau (2 shared papers)Julian Adams (2 shared papers)Peter J. Elliott (2 shared papers)Christine Pien (2 shared papers)Teresa A. McCormack (1 shared paper)Joan S. Brugge (3 shared papers)Ronald K. Blackman (1 shared paper)Seth Sadis (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (5 papers)Proceedings of the National Academy of Sciences (4 papers)Journal of the American Chemical Society (2 papers)Biochemistry (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Eric S. Lightcap
31 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 91
- Oncology 441
- Molecular Biology 1.1k
- Cell Biology 215
- Hematology 134
- Cancer Research 161
Countries citing papers authored by Eric S. Lightcap
This map shows the geographic impact of Eric S. Lightcap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Lightcap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Lightcap more than expected).
Fields of papers citing papers by Eric S. Lightcap
This network shows the impact of papers produced by Eric S. Lightcap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Lightcap. The network helps show where Eric S. Lightcap may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric S. Lightcap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 243 | |
| 2 | 2000 | 215 | |
| 3 | 2002 | 159 | |
| 4 | 2010 | 142 | |
| 5 | 2007 | 117 | |
| 6 | 2012 | 85 | |
| 7 | 2012 | 67 | |
| 8 | 2011 | 58 | |
| 9 | 2019 | 48 | |
| 10 | 2014 | 45 | |
| 11 | 2005 | 24 | |
| 12 | 1996 | 23 | |
| 13 | 1992 | 19 | |
| 14 | 2003 | 17 | |
| 15 | 2023 | 16 | |
| 16 | 2023 | 12 | |
| 17 | 2024 | 10 | |
| 18 | 1991 | 9 | |
| 19 | 2003 | 7 | |
| 20 | 1991 | 6 |
About Eric S. Lightcap
Eric S. Lightcap is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cell Biology and Immunology, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (13 papers), Cancer-related Molecular Pathways (5 papers), Protein Degradation and Inhibitors (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Cancer Cells and Metastasis (3 papers), Metabolism and Genetic Disorders (3 papers), Chemical Reaction Mechanisms (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (441 citations), Molecular Biology (1.1k citations), Cell Biology (215 citations), Hematology (134 citations) and Cancer Research (161 citations). Eric S. Lightcap has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Vincent Chau, Julian Adams, Peter J. Elliott, Christine Pien, Teresa A. McCormack, Joan S. Brugge, Ronald K. Blackman, Seth Sadis, James Fleming and Christine Bulawa. Their work appears in journals such as Molecular Cancer Therapeutics, Proceedings of the National Academy of Sciences, Journal of the American Chemical Society, Biochemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.